IMMEDICA PHARMA AB

Italy

All drugs from this manufacturer

  • AMMONAPS

    It is prescribed to treat urea cycle disorders. It helps the body eliminate nitrogen waste by reducing the amount of ammonia present in the body.

    Dosage form: tablets

    Active substance Dosage
    phenylbutyrate sodium -

    ATC: A16AX03

  • BETOPTIC

    This medicine is used to treat intraocular hypertension and chronic open-angle glaucoma, acting to reduce the pressure inside the eye.

    Dosage form: solution, eye

    Active substance Dosage
    betaxolol hydrochloride -

    ATC: S01ED02

  • CUSIMOLOL

    It is used to reduce pressure inside the eye in cases of ocular hypertension or diseases such as open-angle glaucoma and secondary glaucoma.

    Dosage form: solution, eye

    Active substance Dosage
    timolol maleate -

    ATC: S01ED01

  • EMADINE

    This medicinal product is used to treat seasonal allergic conjunctivitis of the eye, acting to reduce the intensity of the allergic reaction caused by factors such as pollen, dust, or animal hair.

    Dosage form: solution, eye

    Active substance Dosage
    emedastine fumarate -

    ATC: S01GX06

  • FLAREX

    This medicine is used to treat eye inflammations that require the use of a corticosteroid.

    Dosage form: drops, ophthalmic

    Active substance Dosage
    fluorometholone acetate -

    ATC: S01BA07

  • LOARGYS

    It is used for the treatment of arginase 1 deficiency (ARG1-D), also known as hyperargininemia, in adults, adolescents, and children from 2 years of age.

    Dosage form: solution for injection or infusion

    Active substance Dosage
    pegzilarginasi -

    ATC: A16AB24

  • RAVICTI

    It is used to treat six different urea cycle disorders (UCD) in adults and children. These disorders prevent the body from correctly eliminating nitrogen derived from proteins, causing an accumulation of ammonia that can be harmful to the brain.

    Dosage form: solution, for gastric lavage

    Active substance Dosage
    glycerol felbutirate -

    ATC: A16AX09

  • ZTALMY

    It is used for the treatment of a rare disease characterized by seizures called 'cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder' in patients aged between 2 and 17 years. The drug works by reducing the number of daily seizures.

    Dosage form: suspension, oral

    Active substance Dosage
    ganaxolone -

    ATC: N03AX27